Li, N., Guha, U., Kim, C., Ye, L., Cheng, J., Li, F., . . . Wong, D. T. W. (2020). Longitudinal Monitoring of EGFR and PIK3CA Mutations by Saliva-Based EFIRM in Advanced NSCLC Patients With Local Ablative Therapy and Osimertinib Treatment: Two Case Reports. Front Oncol.

Li, Ning, Udayan Guha, Chul Kim, Leah Ye, Jordan Cheng, Feng Li, David Chia, Fang Wei, and David T. W. Wong. "Longitudinal Monitoring of EGFR and PIK3CA Mutations By Saliva-Based EFIRM in Advanced NSCLC Patients With Local Ablative Therapy and Osimertinib Treatment: Two Case Reports." Front Oncol 2020.

Li, Ning, et al. "Longitudinal Monitoring of EGFR and PIK3CA Mutations By Saliva-Based EFIRM in Advanced NSCLC Patients With Local Ablative Therapy and Osimertinib Treatment: Two Case Reports." Front Oncol 2020.